Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Lonza acquires DHA-business from Nutrinova, a subsidiary of Celanese Corporation
Lonza has acquired Nutrinova’s DHA business including know-how, patents and registrations in the major global markets; The proprietary fermentation technology of the acquired DHA business provides exclusive access to a unique production strain.
- Lonza acquires DHA-business from Nutrinova, a subsidiary of Celanese Corporation
Lonza has acquired Nutrinova’s DHA business including know-how, patents and registrations in the major global markets; The proprietary fermentation technology of the acquired DHA business provides exclusive access to a unique production strain.
- Lonza acquires DHA-business from Nutrinova, a subsidiary of Celanese Corporation
Lonza has acquired Nutrinova’s DHA business including know-how, patents and registrations in the major global markets; The proprietary fermentation technology of the acquired DHA business provides exclusive access to a unique production strain.
- Lonza acquires DHA-business from Nutrinova, a subsidiary of Celanese Corporation
Lonza has acquired Nutrinova’s DHA business including know-how, patents and registrations in the major global markets; The proprietary fermentation technology of the acquired DHA business provides exclusive access to a unique production strain.
- Lonza acquires DHA-business from Nutrinova, a subsidiary of Celanese Corporation
Lonza has acquired Nutrinova’s DHA business including know-how, patents and registrations in the major global markets; The proprietary fermentation technology of the acquired DHA business provides exclusive access to a unique production strain.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- BioGaia´ s Investment In Far East Gives Results
Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan, in an expired contract which has now been renegotiated on improved terms. Caompany has also signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets.
- BioGaia´ s Investment In Far East Gives Results
Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan, in an expired contract which has now been renegotiated on improved terms. Caompany has also signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets.
- BioGaia´ s Investment In Far East Gives Results
Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan, in an expired contract which has now been renegotiated on improved terms. Caompany has also signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets.
- BioGaia´ s Investment In Far East Gives Results
Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan, in an expired contract which has now been renegotiated on improved terms. Caompany has also signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets.
- BioGaia´ s Investment In Far East Gives Results
Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan, in an expired contract which has now been renegotiated on improved terms. Caompany has also signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets.
- Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd
Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week.
- Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd
Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week.
- Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd
Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week.
- Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd
Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week.
- Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd
Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week.
- Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd
Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week.
- Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd
Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week.
- Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd
Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week.
- Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd
Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week.
- Bioriginal Extends Flavored EFA Oil Portfolio
Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors.
- Bioriginal Extends Flavored EFA Oil Portfolio
Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors.
- Bioriginal Extends Flavored EFA Oil Portfolio
Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors.
- Bioriginal Extends Flavored EFA Oil Portfolio
Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors.
- Bioriginal Extends Flavored EFA Oil Portfolio
Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors.
- Bioriginal Extends Flavored EFA Oil Portfolio
Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors.
- Bioriginal Extends Flavored EFA Oil Portfolio
Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients
Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients.
- Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients
Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients.
- Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients
Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients.
- Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients
Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients.
- Biogaia Signs Agreement With Novartis Consumer Health SA
BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies.
- Biogaia Signs Agreement With Novartis Consumer Health SA
BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies.
- Biogaia Signs Agreement With Novartis Consumer Health SA
BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies.
- Biogaia Signs Agreement With Novartis Consumer Health SA
BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies.
- LycoRed Launches New Corporate Image
LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials.
- LycoRed Launches New Corporate Image
LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials.
- LycoRed Launches New Corporate Image
LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials.
- LycoRed Launches New Corporate Image
LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials.
- LycoRed Launches New Corporate Image
LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials.
- Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications
URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets.
- Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications
URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets.
- Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications
URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets.
- Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications
URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets.
- Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications
URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets.
- Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications
URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets.
- Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications
URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- Tate & Lyle Interim Results Announcement 2009
Tate & Lyle has announced their 2009 Interim results, reporting the Group's performance, before the impact of exchange translation, remains on track to meet our expectations for the full year.
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Taming Fear of the H1N1 Flu Vaccine
- Taming Fear of the H1N1 Flu Vaccine
- Natural Cold and Flu Remedies: Do They Help?
- Natural Cold and Flu Remedies: Do They Help?
- Exercise as Pain Therapy
- Exercise as Pain Therapy
|
Milan, January 16th, 2005 --The Italian Group Indena, world leader in the identification, development and production of active principles derived from plants, has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including the well known brands PHYTELENES® and COSMELENE® to the French phytocosmetic specialists Greentech S.A..
The deal follows on from Indena’s decision to focus its cosmetic sector resources on the development of highly purified active principles and on standardized dry extracts. These may be either for topical or oral use and are fruit of Indena research work often in collaboration with leading cosmetic companies.
The agreement allows Greentech S.A., which has long been operating in the extract and active ingredients markets, to pursue further development, enrich its product range, and to create and strengthen partnerships both in France and elsewhere. A new purpose-built production facility is under construction.
Later in the year, Indena and Greentech S.A. will be taking part in two of the most important international sector trade fairs, In–Cosmetics and Ingredients Beyond Beauty. These will take place respectively in Barcelona (April 4th – 6th) and in Paris (September 11th – 13th).
The final agreement will be signed by February 15th, 2006.
For further information: www.indena.com www.greentech.fr
Contacts at Indena: - Jean Marc Laquière - Indena France S.A. , jeanmarc.laquiere@indena.com - Christian Artaria - Indena S.p.A., christian.artaria@indena.com
Contacts at Greentech S.A.: - Jean-Yves Berthon - Greentech S.A., greentech@greentech.fr - Véronique Jay-Debaut - Greentech S.A., veroniquejaydebaut@greentech.fr |